T Cell Immunity to Lymphoma Following Treatment with Anti-CD40 Monoclonal Antibody-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

T Cell Immunity to Lymphoma Following Treatment with Anti-CD40 Monoclonal Antibody

Published:2002-03-15 Issue:6 Volume:168 Page:2720-2728
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Tutt Alison L.,O’Brien Lyn,Hussain Akmal,Crowther Graham R.,French Ruth R.,Glennie Martin J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Clinical trials of antibody therapy

2. Discussion

3. A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens

4. Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor immune microenvironment (TIME) to enhance antitumor immunity;European Journal of Medical Research;2023-05-13

2. Synthetic STING agonists elicit powerful vaccine adjuvancy providing robust central memory and anti-tumour effects;2023-01-04

3. Emerging immunotherapeutic strategies for the treatment of breast cancer;Breast Cancer Research and Treatment;2021-10-30

4. Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy;Expert Opinion on Biological Therapy;2021-06-17

5. Overcoming Cancer Tolerance with Immune Checkpoint Blockade;Cancer Immunology;2020-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP